🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Philip C. Prorok

National Cancer Institute

ORCID: 0000-0002-2126-5847
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program”.

Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program

Cancer Prevention Research(2025)10.1158/1940-6207.capr-23-0461
N/A
0.412DataRank · unranked
11 citations

Jill P. Crandall, Sharon L. Edelstein, Philip C. Prorok, Dana Dabelea, Richard F. Hamman +9 more

Cancer screening with multicancer detection tests: A translational science review

CA A Cancer Journal for Clinicians(2024)10.3322/caac.21833
N/A
0DataRank · unranked
69 citations

Christos Patriotis, Anthony Dickherber, Paul K. J. Han, Hormuzd A. Katki, Elyse LeeVan +7 more

Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae218
N/A
0DataRank · unranked
7 citations

Philip C. Prorok, Philip E. Castle, Lori M. Minasian, Paul F. Pinsky, Hormuzd A. Katki

Retracted and Replaced: Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae083
N/A
0DataRank · unranked
5 citations

Philip C. Prorok, Philip E. Castle, Lori M. Minasian, Paul F. Pinsky, Hormuzd A. Katki

Design of randomized controlled trials to estimate cancer-mortality reductions from multicancer detection screening

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae247
N/A
0DataRank · unranked
5 citations

Philip C. Prorok, Hormuzd A. Katki, Ping Hu

Framework to Select Multi-Cancer Detection Assays in the National Cancer Institute’s Vanguard Study

Cancer Epidemiology Biomarkers & Prevention(2025)10.1158/1055-9965.epi-25-0903
N/A
0DataRank · unranked
7 citations

Amanda L. Skarlupka, Christos Patriotis, Wendy S. Rubinstein, Paul F. Pinsky, Wade E. Bolton +12 more